Selhorn Ryan J 4
4 · AYTU BIOPHARMA, INC · Filed Nov 13, 2024
Insider Transaction Report
Form 4
Selhorn Ryan J
Chief Financial Officer
Transactions
- Award
Common Shares
2024-11-11+14,000→ 15,895 total
Footnotes (1)
- [F1]Represents shares of restricted stock which vest as follows: One-third on November 11, 2025; 1/12th of the original grant quarterly thereafter through November 11, 2027.